Correlation Between Akero Therapeutics and Moderna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Moderna, you can compare the effects of market volatilities on Akero Therapeutics and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Moderna.

Diversification Opportunities for Akero Therapeutics and Moderna

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Akero and Moderna is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Moderna go up and down completely randomly.

Pair Corralation between Akero Therapeutics and Moderna

Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.93 times more return on investment than Moderna. However, Akero Therapeutics is 1.08 times less risky than Moderna. It trades about 0.14 of its potential returns per unit of risk. Moderna is currently generating about -0.3 per unit of risk. If you would invest  2,971  in Akero Therapeutics on August 27, 2024 and sell it today you would earn a total of  302.00  from holding Akero Therapeutics or generate 10.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Akero Therapeutics  vs.  Moderna

 Performance 
       Timeline  
Akero Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Moderna 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Akero Therapeutics and Moderna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akero Therapeutics and Moderna

The main advantage of trading using opposite Akero Therapeutics and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.
The idea behind Akero Therapeutics and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA